Orthopedics Medical News about osteoporosis

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Rapid correction of low vitamin D status in nursing home residents

3. 2008 Exclusive Survey—Earnings: Good news for primary care income

4. Medicare pay-for-reporting effort draws fire from frustrated doctors

5. Debunking Myths in the US Healthcare System

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

New therapies for osteoporosis: Zoledronic acid, bazedoxifene, and denosumab
Current Osteoporosis Reports, 09/09/09

Silverman SL – Zoledronic acid significantly reduced the risk of vertebral, nonvertebral, and hip fractures in postmenopausal women. Denosumab is a monoclonal receptor activator of nuclear factor–kB ligand antibody given by subcutaneous injection every 6 months that has been shown to significantly reduce risk of vertebral–, nonvertebral–, and hip fracture in postmenopausal women. Bazedoxifene, an estrogen agonist/antagonist, has significantly reduced the risk of vertebral fracture in postmenopausal women; a post hoc analysis showed reduction in risk of nonvertebral fracture in high–risk women.

<< Previous
Reducing radiation exposure in intra-medullary nailing...

Next >>
Diclofenac sodium gel in patients with primary hand...

Osteologix to Continue Development of Osteoporosis Drug
Internet Source, 10/21/09 Relevance Score: 93%

Lifestyle increases osteoporosis risk: docs
Internet Source, 10/21/09 Relevance Score: 90%

Reducing hip fracture risk with risedronate in elderly women with established osteoporosis
Clinical Interventions in Aging, 11/12/09 Relevance Score: 89%

A microarray based identification of osteoporosis-related genes in primary culture of human osteoblasts
Bone, 10/27/09 Relevance Score: 89%

Evaluation of Compliance with Osteoporosis Treatment Guidelines After Initiation of a Pharmacist-Run Osteoporosis Service at a Family Medicine Clinic
Annals of Pharmacotherapy, 10/15/09 Relevance Score: 89%